Navigation Links
Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
Date:3/13/2008

NGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial for PROVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercialization of PROVENGE, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at http://www.sec.gov.

DENDREON CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

Three months ended Year ended

December 31, December 31,

2007 2006 2007 2006

Revenue $28 $86 $743 $273

Operating expenses:

Research and development 21,743 17,092 76,523 74,088

General and administrative 5,382 6,907 25,839 23,541

Total operating expenses 27,125 23,999 102,362 97,629

Loss from operations (27,097) (23,913) (101,619) (97,356)

Interest income 1,717 1,410 6,461 6,050

Interest expense (1,571) 1,017 (4,106) (336)

Ne
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
9. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
10. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... SCOTTSDALE, Ariz., Dec. 2 MedPre...ceutical competitive intelligence and market,rese...l strategic insight for,pharma and biotech compan...sease (PD) therapies. This report, entitled Thoug...isease, is based on 9 interviews conducted with PD...
(Date:12/2/2008)... Managing the transition from perimenopause to po...ewswire/ -- The increasing frequency and intensity...periencing menopause. OBG Management and The Jo...a supplement titled Vasomotor symptoms: Managing ... . In this supplement, James McGregor, MD, CM and ...
(Date:12/2/2008)... TAMPA, Fla., Dec. 2 Associated C...ology group practice that operates seven locations...has selected Sage Intergy EHR,electronic health r...on. The,Cherry Hill, N.J.-based practice, which c... deploy the single-database, integrated solution t...
(Date:12/2/2008)... On Track to File NDA with FDA in Early to Mid-20...wire-FirstCall/ -- Strativa Pharmaceuticals, the p... Companies, Inc. (NYSE: PRX ) today announced th...he successful completion of all pivotal bioequival...etron. The ondansetron thin film product is being ...
Breaking Biology Technology:New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 4Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4
...is. - Quick quiz: Which Wisconsin institutions sp...fe sciences? , ,Naming No. 1 is relatively easy: t...) is perennially among the top academic R&D center... Medical College of Wisconsin ($139 million), whi...ch centers. Next up is the University of Wisconsi...
...is. - Scott VanderSanden, who has served as vice ...n since 2001, has been appointed president of AT&...n, who has been with AT&T for 17 years, is credite...ulatory initiatives, including the company,s bid t...e. He also directed the company,s activities in a ...
...is. - The Medical College of Wisconsin has been...study pain relief methods for patients with advanc...e with the services of palliative care consultatio...conditions and activities that lead to better pain...atisfaction with care. , ,The National Cancer Ins...
...ls, Wis. - Cray Inc. , the Seattle-based superco...pment center here, has been awarded a $250 million...d Research Projects Agency to develop what the co...However, the agreement,s impact on Cray,s Chippewa..., which extends Cray,s part in DARPA,s High Produc...
Other Biology Technology:Marshfield Clinic and UW combine to speed tech growth 2Marshfield Clinic and UW combine to speed tech growth 3Marshfield Clinic and UW combine to speed tech growth 4Cray signs $250M deal to develop supercomputer 2
(Date:12/2/2008)...d filter-feeding habits, clams have been silent wi...upon their waters. These clams are silent no more...Sea Lab and her colleagues have reported in their ...iology . Using stable isotope techniques, Carmich...ace wastewater inputs to estuaries and coastal foo...
(Date:12/2/2008)... United States that are at the highest risk of sus...g enough to the dangers posed by rising temperatur...f century of climate change that has already signi...tterns and has already had widespread ecological a...nty that the United States will experience at leas...
(Date:12/2/2008)...an anywhere else in the world. This is having a ma...ban environment and effect of cities on rural area... Africa,s history is being over-looked. , Joy Cl...e problem in the current issue of the African Jou...% of the African population was rural, today 38% l...
(Date:12/2/2008)...rschungsgemeinschaft (DFG, German Research Foundat...ntres. They will be initially funded for the next ...n euros. Among other things, the new Collaborative...es caused by viruses and bacteria, scarring of the...cs include the optimisation of planning, productio...
Breaking Biology News(10 mins):Most US organizations not adapting to climate change 2Most US organizations not adapting to climate change 3From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 2From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 3From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 4From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 5From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 6From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 7Evolution Physical Therapy First Clinic in Southern California to Introduce NASA Designed Anti Gravity Treadmill for Public Use 28112 1Evolution Physical Therapy First Clinic in Southern California to Introduce NASA Designed Anti Gravity Treadmill for Public Use 28112 2Evolution Physical Therapy First Clinic in Southern California to Introduce NASA Designed Anti Gravity Treadmill for Public Use 28112 3WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke 28108 1WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke 28108 2WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke 28108 3Santa Monica School Unveils Fresh Fruit 26 Vegetable Snack Program to Combat Obesity 28106 1Santa Monica School Unveils Fresh Fruit 26 Vegetable Snack Program to Combat Obesity 28106 2CareAnalyzer From DST Health Solutions Helps Health Plans Improve Care Management and Quality for Members 28102 1CareAnalyzer From DST Health Solutions Helps Health Plans Improve Care Management and Quality for Members 28102 2
...mportant counter-balance to the warming of our pla... pollution and other aerosol particles ?appears to...creen" of aerosols since the early 1990s could hav...e temperatures. The finding, published today in th...anding of recent climate change. In a related stud...
... births resulting from in-vitro-fertilization (IVF...ll University have developed a procedure that esti...ryos, possibly leading to a decrease in multiple-i...dergoing IVF. , Over 100,000 in-vitro fertilizatio... States. In 2002, 3.1 embryos on average were tran...
...l bacteria in laboratory experiments and eliminate...g with a key bacterial nutrient, according to rese...The joint project, conducted at the UW, the Univer...ll be featured in the April 2 issue of the Journal...singly resistant to antibiotics, and existing drug...
...flash of light are providing insight into the comp...yield a better understanding of how the human brai...l Center and the Howard Hughes Medical Institute h...ain cells "fire" when exposed to light. This was a...urally present in green algae that "turns on" when...
Other Biology News:Global 'sunscreen' has likely thinned, report NASA scientists 2Global 'sunscreen' has likely thinned, report NASA scientists 3Trojan horse strategy defeats drug-resistant bacteria 2Common algae helps illustrate mammalian brain electrical circuitry 2Common algae helps illustrate mammalian brain electrical circuitry 3
2,4-Dinitrophenyl hapten is conjugated to Keyhole Limpet (KLH) protein through lysine.
IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is
ANTI GELSOLIN
Biology Products: